Novartis AG
Novel Pyrazolo Pyrimidine Derivatives
Last updated:
Abstract:
The present invention describes new pyrazolo-pyrimidine derivatives which are generally interacting with MALT1 proteolytic and/or autoproteolytic activity, and in particular which may inhibit said activity. The present invention further describes the synthesis of said new pyrazolo-pyrimidine derivatives, their use as a medicament, especially by interacting with MALT1 proteolytic and/or autoproteolytic activity.
Status:
Application
Type:
Utility
Filling date:
11 Nov 2016
Issue date:
17 Sep 2020